what's the difference between bpc 157 and bpc 159 BPC-157 Benefits, Dosage & Before/After Results BPC-157 vs GHK-Cu vs TB-500:

Skin sensitivity: an emerging signal Skin burning and abnormal touch sensitivity (dysesthesia) appears as a dose-related, reversible signal in two case series and post-market surveillance. Trials did not pre-specify it, and the tirzepatide label does not list it

A subset of prescribers combine oral and subcutaneous administration simultaneously (e.g., 250 mcg oral in the morning plus 250 mcg subcutaneous in the evening)

The intravenous safety study published in 2025 involved only 2 participants

If it involves immune dysregulation, then immunomodulation deserves investigation

I hope you love it as much as I do, and that it helps you achieve the beautiful, healthy skin you deserve

For patients with adequate levels, the injections are unlikely to deliver the dramatic results that marketing materials suggest